These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 2200808

  • 1. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG, Swinburn B, Ruotolo G, Hara H, Patti L, Harper I, Grundy SM, Howard BV.
    J Clin Invest; 1990 Aug; 86(2):642-50. PubMed ID: 2200808
    [Abstract] [Full Text] [Related]

  • 2. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy.
    Taskinen MR, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV.
    Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of metabolic effects of substitution of complex carbohydrates for saturated fat in individuals with obesity and NIDDM.
    Howard BV, Abbott WG, Swinburn BA.
    Diabetes Care; 1991 Sep; 14(9):786-95. PubMed ID: 1959472
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G, Beltz WF, Grundy SM, Howard BV.
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [Abstract] [Full Text] [Related]

  • 8. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ.
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [Abstract] [Full Text] [Related]

  • 9. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men.
    Riches FM, Watts GF, Hua J, Stewart GR, Naoumova RP, Barrett PH.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2854-61. PubMed ID: 10443691
    [Abstract] [Full Text] [Related]

  • 10. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
    Millar JS, Lichtenstein AH, Cuchel M, Dolnikowski GG, Hachey DL, Cohn JS, Schaefer EJ.
    J Lipid Res; 1995 Jun; 36(6):1155-67. PubMed ID: 7665994
    [Abstract] [Full Text] [Related]

  • 11. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [Abstract] [Full Text] [Related]

  • 12. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR.
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Huff MW.
    Biochim Biophys Acta; 1998 Jul 31; 1393(1):63-79. PubMed ID: 9714740
    [Abstract] [Full Text] [Related]

  • 14. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet.
    Stacpoole PW, von Bergmann K, Kilgore LL, Zech LA, Fisher WR.
    J Lipid Res; 1991 Nov 31; 32(11):1837-48. PubMed ID: 1770303
    [Abstract] [Full Text] [Related]

  • 15. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
    Pont F, Duvillard L, Florentin E, Gambert P, Vergès B.
    Arterioscler Thromb Vasc Biol; 2002 Oct 01; 22(10):1726-32. PubMed ID: 12377756
    [Abstract] [Full Text] [Related]

  • 16. Dependence of plasma alpha-tocopherol flux on very low-density triglyceride clearance in humans.
    Parks EJ, Dare D, Frazier KB, Hellerstein MK, Neese RA, Hughes E, Traber MG.
    Free Radic Biol Med; 2000 Dec 01; 29(11):1151-9. PubMed ID: 11121723
    [Abstract] [Full Text] [Related]

  • 17. Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.
    Taskinen MR, Matikainen N, Björnson E, Söderlund S, Inkeri J, Hakkarainen A, Parviainen H, Sihlbom C, Thorsell A, Andersson L, Adiels M, Packard CJ, Borén J.
    Diabetologia; 2023 Dec 01; 66(12):2307-2319. PubMed ID: 37775612
    [Abstract] [Full Text] [Related]

  • 18. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
    Howard BV.
    Diabetes Care; 1993 Jan 01; 16(1):284-91. PubMed ID: 8422793
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D.
    J Lipid Res; 2000 Feb 01; 41(2):305-18. PubMed ID: 10681415
    [Abstract] [Full Text] [Related]

  • 20. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG, Patsch W, Kuisk I, Gonen B, Schonfeld G.
    J Clin Endocrinol Metab; 1983 Jun 01; 56(6):1108-15. PubMed ID: 6841553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.